United Therapeutics Corp

United Therapeutics Corp Stock

21.67P/E
€21.70BMarket capitalisation
US$26.49Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United Statesand Rest of the World, of which United States generates majority of the revenue.

United Therapeutics Corp is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the United Therapeutics Corp stock.

Market capitalisation
€21.70B
P/E
21.67
P/B
3.59
P/S
8.35
P/CF
14.93
Issued shares 43M Units

Return

Here you can see the performance of the United Therapeutics Corp stock.

PeriodPerfor­mance
1 Week-5.64 %
1 Month+11.42 %
3 Months+4.02 %
6 Months-1.36 %
1 Year+29.98 %
YTD+12.18 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the United Therapeutics Corp share.

DateRatio
23.09.20091:0.5

Which ETF contains the United Therapeutics Corp stock?

The United Therapeutics Corp stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, United Therapeutics Corp has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the United Therapeutics Corp stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.